SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma informs about open offer

09 Jun 2026 Evaluate
Bliss GVS Pharma has informed that SBI Capital Markets (Manager to the Open Offer) has submitted a copy of Draft Letter of Offer to the Public Shareholders of Bliss GVS Pharma (Target Company). 

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

423.70 3.15 (0.75%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.10
Dr. Reddys Lab 1271.75
Cipla 1376.25
Zydus Lifesciences 1097.90
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×